PetMed Express CEO awarded 250K shares, 250K units

Q: When do PETS restricted shares vest?

The 250,000 restricted shares vest as to one-third of the grant on each of the first three grant anniversaries, subject to continued employment. Accelerated vesting applies upon death, disability, a change of control, or certain terminations of employment.

Q: What performance condition applies to PETS PSUs?

Each PSU represents a contingent right to receive one common share if predetermined levels of PetMed Express’s total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over the three-year performance period ending September 27, 2029.

The awards have separate terms: restricted shares vest over three anniversaries, while PSUs depend on relative shareholder returns through September 27, 2029.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

PetMed Express CEO and President Jeffrey Allen Willard received a 250,000-share restricted stock award and 250,000 Performance Share Units (PSUs) on September 28, 2026. His reported post-grant positions were 250,000 common shares and 250,000 PSUs. The restricted shares vest one-third on each of the first three grant anniversaries, subject to continued employment, with accelerated vesting upon death, disability, a change of control, or certain terminations. Each PSU is a contingent right to one common share if predetermined levels of the company’s total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over the three-year performance period ending September 27, 2029.

Insider Trade Summary

Grant/Award: 500,000 shares

Grant/Award 2 txns

Insider Willard Jeffrey Allen

Role CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Performance Share Units ^F2	250,000	$0.00	$0.00
Grant/Award	Common Stock ^F1	250,000	$0.00	$0.00

Holdings After Transaction: Performance Share Units — 250,000 contracts (Direct); Common Stock — 250,000 shares (Direct)

Footnotes (2)

F1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment.
F2. Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029.

Key Figures

Restricted stock award: 250,000 shares Performance Share Units: 250,000 units Reported post-grant common shares: 250,000 shares +3 more

6 metrics

Restricted stock award 250,000 shares Granted September 28, 2026

Performance Share Units 250,000 units Granted September 28, 2026

Reported post-grant common shares 250,000 shares Jeffrey Allen Willard’s reported position after the award

Reported post-grant PSUs 250,000 units Jeffrey Allen Willard’s reported position after the grant

Restricted-share vesting One-third on each of the first three grant anniversaries Subject to continued employment

PSU performance period Three years Ends September 27, 2029

Key Terms

restricted stock award, Performance Share Units ("PSUs"), accelerated vesting, total shareholder return

4 terms

restricted stock award financial

"Consists of a restricted stock award"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

accelerated vesting financial

"subject to accelerated vesting upon death, disability, a change of control"

A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.

total shareholder return financial

"total shareholder return relative to the S&P 600 Specialty Retail Index"

Total shareholder return is the overall gain an investor gets from owning a stock, combining changes in the share price plus any cash payouts like dividends, and assuming those payouts are reinvested in more shares. Investors use it like a single score that shows the true return on their investment—similar to checking both the growth of a savings account and the interest earned—to compare how well different companies or investments perform over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares and PSUs did PETS CEO Jeffrey Allen Willard receive?

Jeffrey Allen Willard, CEO and President, received a restricted stock award for 250,000 common shares and a grant of 250,000 Performance Share Units on September 28, 2026. His reported post-grant positions were 250,000 common shares and 250,000 PSUs.

When do PETS restricted shares vest?

The 250,000 restricted shares vest as to one-third of the grant on each of the first three grant anniversaries, subject to continued employment. Accelerated vesting applies upon death, disability, a change of control, or certain terminations of employment.

What performance condition applies to PETS PSUs?

Each PSU represents a contingent right to receive one common share if predetermined levels of PetMed Express’s total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over the three-year performance period ending September 27, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/29/2026 - 04:36 PM Accepted by SEC EDGAR 09/29/2026 - 04:36 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Willard Jeffrey Allen

(Last)

(First)

(Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH

FLORIDA

33445

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/28/2026		A		250,000⁽¹⁾	A	$0	250,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Share Units	⁽²⁾	09/28/2026		A		250,000		⁽²⁾	09/28/2029	Common Stock	250,000	$0	250,000	D

Explanation of Responses:

1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death, disability, a change of control, or certain terminations of employment.

2. Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on September 27, 2029.

Remarks:

	/s/ Jeffrey Allen Willard	09/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR